A Phase 2 interventional study of DIMS lenses in Myopia, sponsored by The Hong Kong Polytechnic University. Recruiting at 1 site in Hong Kong. Open to participants aged 6 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-02.
Sponsored by The Hong Kong Polytechnic University · Phase 2, Interventional, and Treatment
Myopia has become a world concern and its prevalence has increased in recent decades. Myopic defocus has been applied for slowing down the axial elongation and myopia progression, which is mainly based on the theory of simultaneous competing defocus and peripheral optics. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses impose myopic defocus in the central or peripheral retina, with myopia progression being retarded by 50% to 60%. However, the optimal amount of myopic defocus has not yet been determined. Relative peripheral refraction (RPR) is used to indicate the difference between peripheral refraction and central refraction. Previous studies showed that retinal shape determined RPR, and baseline RPR may influence the myopia control efficacy using DIMS lenses on myopic children. It is still unclear if any other unknown factor influenced the final myopia control outcome in these young children with myopic RPR at baseline. Unlike our previous study8 that bias on hyperopic RPR children (myopic RPR, n = 27; hyperopic RPR, n = 52), this study is a case-control study with the same sample size for each RPR group. We will also include younger children who are more prone to have myopic RPR and develop high myopia. The results should provide new insight into the myopia control strategy in early-onset myopic children.
In the current study, we will investigate the influence of baseline RPR in myopia retardation using DIMS lenses among young myopic children.
This will ba a 1-year prospective clinical trial. Through G*Power (version 3.1.9.6) calculation, 80 healthy myopic subjects (40 myopic RPR vs 40 hyperopic RPR) aged 5-9 years should be needed. After screened by inclusion criteria, eligible participants will be assigned to wear DIMS lenses for 1 year (12 months, 8 hour per day, 7 days per week). This study includes 5 visits: Visit 1: baseline, Visit 2: lens dispensing, Visit 3: 2-week follow-up, Visit 4: 6-month follow-up, and Visit 5: 12-month follow-up. All eye examinations will be carried out in the Optometry Research Centre (A137), the School of Optometry, the Hong Kong Polytechnic University. The main data collection, including refractive error, axial length, related ocular parameters will be measured at baseline, 6-month and 1-year visits. At the lens dispensing and 2-week follow-up visits, vision acuity testing and computer scanning of posterior eyes will be measured. New DIMS lens will be replaced and upgraded if the equivalent sphere of refraction (SER) is changed or visual acuity change.
The following data will be statistically analyzed. The primary outcome data include the difference in change in SER with cycloplegia between the myopic and hyperopic RPR from the baseline over 12 months of treatment. Secondary outcomes data include the changes in axial length, peripheral refraction, relative peripheral refraction, the amplitude of accommodation, lag of accommodation, corneal curvature, phoria and stereoacuity.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's planned enrollment of 80 is close to the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients with myopic relative peripheral refraction
Device: DIMS lenses
Patients with hyperopic relative peripheral refraction
Device: DIMS lenses
Defocus incorporated multiple segments lenses, which use induce peripheral myopic defocus to control for myopia development in children
Cycloplegic refractive error
Refractive error measured after instillation of cycloplegia
Time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment
Axial length
Length of the eye
Time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment
Peripheral refraction
Refractive errors at peripheral fields
Time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment
Amplitude and lag of accommodation
Ability of the eyes to accommodate
Time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment
Corneal curvature
Power of the cornea
Time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment
Phoria and stereoacuity
Coordination of the two eyes
Time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Hong Kong Polytechnic University